BOTHELL, Wash., Feb. 20 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (NASDAQ:CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it will release its fourth quarter 2007 financial results on Thursday, February 28, 2008 after the market close. The Company also scheduled a conference call with analysts and investors for 4:30 p.m. Eastern Time to discuss the financial results for the fourth quarter and current business developments. The call will be hosted by John Hinson, president and chief executive officer, and Michael Matysik, senior vice president and chief financial officer.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO) To access the conference call, please dial 866-250-2351. International participants can dial 303-262-2131. The call will also be webcast live at http://www.cardiacscience.com/. An audio replay of the call will be available for 7 days following the call at (800) 405-2236 for U.S. callers or (303) 590-3000 for those calling outside the U.S. The password required to access the replay is 11109221#. An archived webcast will also be available at http://www.cardiacscience.com/ for 90 days.
About Cardiac Science Corporation Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425-402-2000 or visit http://www.cardiacscience.com/.
Company Contact:
Mike Matysik
Cardiac Science Corporation
Sr. Vice President and CFO
425-402-2009 Investor Contact:
EVC Group, Inc. Douglas Sherk/Jenifer Kirtland
415-896-6820 Media Contact:
EVC Group, Inc. Christopher Gale
(201) 646-5431
(203) 570-4681
http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO http://photoarchive.ap.org/ DATASOURCE: Cardiac Science Corporation CONTACT: Company, Mike Matysik, Sr. Vice President and CFO of Cardiac Science Corporation, +1-425-402-2009; or Investors, Douglas Sherk or Jenifer Kirtland, +1-415-896-6820; or Media, Christopher Gale, +1-201-646-5431, or +1-203-570-4681, all of EVC Group, Inc., for Cardiac Science Corporation Web site: http://www.cardiacscience.com/
|